Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice

Thomas L. Wallace, Victor Paetznick, Paul A. Cossum, Gabriel Lopez-Berestein, John H. Rex, Elias Anaissie

Research output: Contribution to journalArticle

58 Scopus citations


The purpose of this study was to examine the activity of liposomal nystatin against a disseminated Aspergillus fumigatus infection in neutropenic mice. Mice were made neutropenic with 5-fluorouracil and were administered the antifungal drug intravenously for 5 consecutive days beginning 24 h following infection. Liposomal nystatin, at doses as low as 2 mg/kg of body weight/day, protected neutropenic mice against Aspergillus-induced death in a statistically significant manner at the 50-day time point compared to either the no-treatment, the saline, or the empty-liposome group. This protection was approximately the same as that for free nystatin, a positive control. Histopathological results showed that liposomal nystatin cleared the lungs, spleen, pancreas, kidney, and liver of Aspergillus and that there was no organ damage at the day 5 time point, which was after only three doses of liposomal nystatin. Based on these results in mice, it is probable that liposomal nystatin will be effective against Aspergillus infection in humans.

Original languageEnglish (US)
Pages (from-to)2238-2243
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Issue number10
StatePublished - Oct 1 1997


ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this